Inspiring Better Healthcare
Commercial success in the healthcare sector means putting the patient at the heart of every decision...
Healthcare at Ipsos
What's New?
![]() | POINT OF VIEW Oncology: The Disease, Dynamics & Challenges of Market Research Our 2026 update outlining the considerations and challenges for professionals who market, or conduct marketing research for, oncology products. |
![]() | RESEARCH SOLUTION Ipsos Rx Insight Store Over 80 reports now available across multiple therapy areas and healthcare topics, ensuring access to the most relevant market insights for brand success |
![]() | REPORT The GLP-1 Revolution - What's changed in 2025? As part of Ipsos’ Year in Review, Jackie Ilacqua charts the transformative impact of GLP-1s to date – concluding that if 2024 was the year GLP-1 drugs went mainstream, 2025 is the year they matured… |
![]() | POINT OF VIEW MASH at a Turning Point. Again. Discover how new treatment options for MASH – including GLP‑1, Wegovy – could reshape treatment, pushing diagnosis and management earlier into primary care. |
![]() | POINT OF VIEW Would You Want to Know? As technology improves our diagnostic capabilities, and consumers seek greater understanding and control of their own healthcare, we explore the benefits and risks of early cancer detection. |
![]() | NEW SOLUTION Ipsos Launches GLP-1 PersonaBot Ipsos’ latest innovation, which combines the power of AI with Ipsos Global Consumer Obesity Monitor data, is poised to transform how companies understand and engage with obesity treatment consumers… |





